Table 4.
Antimicrobial susceptibility patterns of gram-negative bacterial isolates (N= 21) among PLHIV attending ART Clinic, WSUTRH, Ethiopia, 2018
| Bacterial Isolate | Classification | Antibiotics | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CXT | NOR | CTR | CFP | GEN | AMC | AMP | NIT | AMK | CPR | ||
| E. coli (n=13) | S | 4 (31%) | 11 (85%) | 6 (46%) | 9 (69%) | 8 (62%) | 0 (0.0) | 0 (0.0) | 9 (69%) | 10 (77%) | 13 (100%) |
| I | 3 (23%) | 2 (23%) | 5 (39%) | 3 (23%) | 1 (8%) | 0 (0.0) | 0 (0.0%) | 2 (23%) | 2 (23%) | 0 (0.0) | |
| R | 6 (46%) | 0 (0.0) | 2 (15%) | 1 (8%) | 4 (31%) | 13 (100%) | 13 (100%) | 2 (23%) | 1 (8%) | 0 (0.0) | |
| K. pneumoniae (n=3) | S | 0 (0.0%) | 2 (67%) | 1 (33%) | 1 (33%) | 0 (0,0) | 0 (0.0) | 0 (0.0) | 3 (100%) | 1 (33%) | 1 (33%) |
| I | 1 (33.3%) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | |
| R | 2 (67%) | 1 (33%) | 2 (67%) | 2 (67%) | 3 (100%) | 3 (100%) | 3 (100%) | 0 (0.0) | 2 (67%) | 2 (67%) | |
| P. mirabilis (n=3) | S | 0 (0.0) | 3 (100%) | 2 (67%) | 2 (67%) | 3 (100%) | 0 (0.0) | 0 (0.0) | 1 (33%) | 2 (67%) | 3 (100%) |
| I | 1 (33%) | 0 (0.0) | 1 (33%) | 1 (33%) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (33%) | 1 (33%) | 0 (0.0) | |
| R | 2 (66.7%) | 0 (0.0) | 0 (0.0) | 0 (0.0) | (0.0) | 3 (10%) | 3 (100%) | 1 (33%) | 0 (0.0) | 0 (0.0) | |
| P. auroginosa (n=2) | S | 1 (50%) | 1 (50%) | 2 (100%) | 2 (100%) | 2 (100%) | 0 (0.0) | 0 (0.0) | 2 (100%) | 1 (50%) | 2 (100%) |
| I | 1 (50%) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | (0.0) | 1 (50%) | 0 (0.0) | |
| R | 0 (0.0) | 1 (50%) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 2 (100%) | 2 (100%) | 0 (0.0) | 0 (0.0) | (0.0) | |
Abbreviations: CXT, cefoxitin; NOR, norfloxacin; CTR, ceftriaxone; CFP, cefepime; GEN, gentamicin; AMP, ampicillin; NIT, nitrofurantoin; AMK, amikacin; CPR, ciprofloxacin; AMC, amoxicillin-clavulanic acid.